Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | C19orf10 |
| Upstream (Parents) |
|---|
| (<<) MCM7 → C19orf10 |
| (<<) POLR2J → C19orf10 |
| (<<) COPE → C19orf10 |
| (<<) PPP1CA → C19orf10 |
| (<<) DNAJB1 → C19orf10 |
| Downstream (Children) |
|---|
| C19orf10 → BAX (>>) |
| C19orf10 → FGF9 (>>) |
| C19orf10 → FEZF2 (>>) |
| C19orf10 → GOLM1 (>>) |
| C19orf10 → F11R (>>) |
| C19orf10 → RPS21P7///C20orf30///SLC23A2 (>>) |
| C19orf10 → IKBKAP (>>) |
| C19orf10 → LRFN4 (>>) |
| C19orf10 → YIPF2 (>>) |
| C19orf10 → KIF25 (>>) |
| C19orf10 → BTF3 (>>) |
| C19orf10 → PCYOX1 (>>) |
| C19orf10 → NCRNA00185 (>>) |
| C19orf10 → YTHDC2 (>>) |
| C19orf10 → SSRP1 (>>) |
| C19orf10 → LMO1 (>>) |
| C19orf10 → HDAC9 (>>) |
| C19orf10 → DNASE2 (>>) |
| C19orf10 → HMG20B (>>) |
| C19orf10 → SNX29 (>>) |
| C19orf10 → SART3 (>>) |
| C19orf10 → NIP7 (>>) |
| C19orf10 → DNAJC17 (>>) |
| C19orf10 → ARL15 (>>) |
| C19orf10 → POLR2J3///POLR2J2///POLR2J4 (>>) |
| C19orf10 → UBTF (>>) |
| C19orf10 → C22orf36 (>>) |
| C19orf10 → SRSF10 (>>) |
| C19orf10 → RASAL1 (>>) |
| C19orf10 → DIS3 (>>) |
| C19orf10 → COL9A1 (>>) |
| C19orf10 → MAN1B1 (>>) |
